Takumi Itoh

Years Active: 2019-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Takumi Itoh, Ryo Hatano, Yoshiya Horimoto, Taketo Yamada, Dan Song, Haruna Otsuka, Yuki Shirakawa, Shuji Mastuoka, Noriaki Iwao, Thomas M Aune, Nam H Dang, Yutaro Kaneko, Ko Okumura, Chikao Morimoto, Kei Ohnuma
IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells. Cell death & disease 12 (6) (2021)
Ryo Hatano, Takumi Itoh, Haruna Otsuka, Sayo Okamoto, Eriko Komiya, Satoshi Iwata, Thomas M Aune, Nam H Dang, Kyoko Kuwahara-Arai, Kei Ohnuma, Chikao Morimoto
Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis. mAbs 11 (8) (2019)
Yuko Matsumura, Yasuhiko Ito, Yoshihiro Mezawa, Kaidiliayi Sulidan, Yataro Daigo, Toru Hiraga, Kaoru Mogushi, Nadila Wali, Hiromu Suzuki, Takumi Itoh, Yohei Miyagi, Tomoyuki Yokose, Satoru Shimizu, Atsushi Takano, Yasuhisa Terao, Harumi Saeki, Masayuki Ozawa, Masaaki Abe, Satoru Takeda, Ko Okumura, Sonoko Habu, Okio Hino, Kazuyoshi Takeda, Michiaki Hamada, Akira Orimo
Stromal fibroblasts induce metastatic tumor cell clusters via epithelial-mesenchymal plasticity. Life science alliance 2 (4) (2019)

Takumi Itoh.css-eqlu8i{font-size:small;padding-left:4px;}